Pharmacovigilance
Showing 1 - 25 of 329
Active Pharmacovigilance of Anti-cancer Medicines
Recruiting
- Oncology
- +2 more
-
Trieste, ItalyIRCCS materno infantile Burlo Garofolo
Apr 11, 2023
EXploring Immune-related Adverse Events of Immune checkpoinT
Active, not recruiting
- Cancer
- +2 more
- Immune checkpoint inhibitor
-
Paris, France
- +1 more
Jul 5, 2023
Immunomodulators Associated With Atrial Fibrillation Reporting:
Completed
- Atrial Fibrillation
- Immunomodulators with FDA approval on the 1st January 2023.
-
Caen, Basse Normandie, FranceAlexandre Joachim
Oct 17, 2023
Adverse Drug Event Trial in Madrid (Pharmacovigilance Program)
Recruiting
- Adverse Drug Event
- Pharmacovigilance Program
-
Madrid, SpainHospital San Carlos
Aug 2, 2022
Dihydropyridine Calcium Channel Inhibitors on Respiratory Gas
Completed
- Hypoxia
- dihydropyridine calcium channel inhibitors use
-
Caen, Normandie, FranceCaen University Hospital, Department of Pharmacology
Sep 8, 2022
Delirium Related to Proton Pump Inhibitors Use
Completed
- Proton Pump Inhibitor Adverse Reaction
- +2 more
-
Caen, FranceCaen University Hospital
Apr 17, 2023
Pharmacists' Knowledge and Attitudes About ADRs Reporting and
Completed
- Adverse Drug Reaction
- knwoledge
-
Fayoum, EgyptMarwa Kamal Ahmed Tolba
Feb 3, 2022
Advanced Melanoma, Hepatitis B, Hepatitis C Trial in Taipei 105
Completed
- Advanced Melanoma
- +2 more
-
Taipei 105, TaiwanLocal Institution
Jan 11, 2022
Heart Failure Trial in Osaka (Samtasu for I.V. infusion)
Not yet recruiting
- Heart Failure
- Samtasu for I.V. infusion
-
Osaka, JapanPharmacovigilance Department
Jan 25, 2023
COVID-19 Vaccines Associated Malaise
Completed
- Vaccine Adverse Reaction
- SARS-CoV-2 vaccine
-
Caen, Normandie, FranceCaen University Hospital, Department of Pharmacology
Apr 29, 2022
Reporting of Antibody-Drug Conjugate Associated Sepsis-related
Completed
- Sepsis (SMQ)
- +2 more
- Antibody-Drug Conjugate
- Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
-
Changsha, Hunan, ChinaCentral South University
Jun 19, 2022
Abilify Prolonged Release Aqueous Suspension for IM Injection
Recruiting
- Bipolar Disorder I
- Abilify prolonged release aqueous suspension for IM injection (Aripiprazole)
-
Osaka, JapanPharmacovigilance Department
Jan 23, 2023
Fed Conditions Trial in Bab Souika (Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg), Galvumet® Film Coated Tablets
Completed
- Fed Conditions
- Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg)
- Galvumet® Film Coated Tablets (850 mg / 50 mg)
-
Bab Souika, Tunise, TunisiaCentre National Chalbi Belkahia de Pharmacovogilance
Oct 22, 2023
Fed Conditions Trial in Tunis (Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®), Metformin /
Completed
- Fed Conditions
- Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®)
- Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg)
-
Tunis, TunisiaCentre National Chalbi Belkahia de Pharmacovogilance
Oct 13, 2023
AJOVY Subcutaneous Injection for Long-term Use
Recruiting
- Migraine Disorders
- Fremanezumab 225 Mg/1.5 mL Subcutaneous Solution
-
Osaka, JapanPharmacovigilance Department
Apr 26, 2022
Radical Cure With Tafenoquine or Primaquine After
Not yet recruiting
- Malaria, Vivax
- Training on revised algorithm
- +6 more
- (no location specified)
Dec 23, 2022
Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
-
Leipzig, GermanyUniversitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
Apr 25, 2023
doTBal® in Tuberculosis: Conduction ofIntensive
Completed
- Tuberculosis
- Rifampicin/ Isoniazid/ Pyrazinamide/ Ethambutol
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Jun 1, 2021
Samsca Post-marketing General Drug Use-results Survey in
Recruiting
- Antidiuretic Hormone, Inappropriate Secretion
- Tolvaptan (SAMSCA)
-
Osaka, JapanPharmacovigilance Department
Apr 6, 2022
Pancytopenia Related to PARP Inhibitors (PancytoRIB)
Completed
- Cancer
- PARP inhibitor
-
Caen, Basse Normandie, FranceAlexandre Joachim
Sep 16, 2021
Transverse Myelitis Related to SARS-CoV-2 Vaccines
Completed
- Vaccine Adverse Reaction
- SARS-CoV-2 vaccines
-
Caen, Basse Normandie, FranceAlexandre Joachim
Jan 3, 2022
CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors
Recruiting
- Myocarditis
- +5 more
-
Paris, FranceAP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
Aug 19, 2022
Pulmonary Toxicities Related to PARP Inhibitors (PulmonaRIB)
Recruiting
- Cancer
- olaparib, rucaparib, niraparib, talazoparib, veliparib, pamiparib
-
Caen, Basse Normandie, FranceAlexandre Joachim
May 27, 2021
Adsorbed COVID-19 (Inactivated) Vaccine
Not yet recruiting
- Covid19
- Adsorbed COVID-19 (Inactivated) Vaccine
-
Botucatu, São Paulo, Brazil
- +2 more
Apr 12, 2021